NewAmsterdam Pharma
Developing transformative, clinically validated oral therapies for patients with metabolic diseases.
Launch date
Employees
Market cap
CAD2.0b
Enterprise valuation
CAD1.4b (Public information from Sep 2024)
Share price
$16.06 NAMS
Naarden North Holland (HQ)
Authorizing premium user...